HomeCompareBDVSY vs PFE

BDVSY vs PFE: Dividend Comparison 2026

BDVSY yields 3.24% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PFE wins by $23.8K in total portfolio value· pulled ahead in Year 9
10 years
BDVSY
BDVSY
● Live price
3.24%
Share price
$27.06
Annual div
$0.88
5Y div CAGR
3.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.7K
Annual income
$589.34
Full BDVSY calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — BDVSY vs PFE

📍 PFE pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBDVSYPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BDVSY + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BDVSY pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BDVSY
Annual income on $10K today (after 15% tax)
$275.18/yr
After 10yr DRIP, annual income (after tax)
$500.94/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, PFE beats the other by $21,818.96/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BDVSY + PFE for your $10,000?

BDVSY: 50%PFE: 50%
100% PFE50/50100% BDVSY
Portfolio after 10yr
$37.6K
Annual income
$13,424.03/yr
Blended yield
35.66%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

BDVSY
No analyst data
Altman Z
3.8
Piotroski
6/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BDVSY buys
0
PFE buys
0
No recent congressional trades found for BDVSY or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBDVSYPFE
Forward yield3.24%6.13%
Annual dividend / share$0.88$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR3.6%13.2%
Portfolio after 10y$25.7K$49.6K
Annual income after 10y$589.34$26,258.71
Total dividends collected$4.5K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: BDVSY vs PFE ($10,000, DRIP)

YearBDVSY PortfolioBDVSY Income/yrPFE PortfolioPFE Income/yrGap
1$11,035$335.39$9,153$693.39+$1.9KBDVSY
2$12,166$358.36$8,593$849.25+$3.6KBDVSY
3$13,400$382.53$8,336$1,066.78+$5.1KBDVSY
4$14,746$407.94$8,437$1,384.80+$6.3KBDVSY
5$16,213$434.66$9,013$1,875.40+$7.2KBDVSY
6$17,811$462.71$10,306$2,680.72+$7.5KBDVSY
7$19,550$492.15$12,820$4,101.38+$6.7KBDVSY
8$21,441$523.03$17,673$6,826.70+$3.8KBDVSY
9← crossover$23,498$555.41$27,543$12,591.86$4.0KPFE
10$25,732$589.34$49,560$26,258.71$23.8KPFE

BDVSY vs PFE: Complete Analysis 2026

BDVSYStock

The Bidvest Group Limited operates in trading, services, and distribution businesses in South Africa and internationally. The company operates through Services, Branded Products, Freight, Automotive, Commercial Products, Financial Services, and Properties segments. It is involved in the online motor retailing and vehicle auctioneering activities; provision of road assistance, vehicle towing, tyre replacement/change, fuel top up, locksmith, and legal advice services; and manufacturing, distribution, and trading of consumer and industrial day-to-day branded products. The company also distributes electrical, cable and allied products, solutions, and services to wholesale, industrial, mining, contractor, construction, engineering, and retail sectors; and provides a range of banking, insurance, foreign exchange, fleet management, asset management, trade finance, financial emigration, wealth externalization, and other financial services for the corporate, business, and individual markets. In addition, it offers freight management services; terminal operations and support, international clearing and freight forwarding, integrated logistics, supply chain solutions, and marine and insurance services; a suite of services relating to office products, office automation, and office furniture; outsourced customer communication services; facilities management, security, travel, aviation, and allied services; and commercial, industrial, financial, automotive, freight, and logistics services, as well as supplies stationery, paper or printer cartridges, and packaging and data services. Further, the company manufactures, markets, and distributes healthcare products; develops, owns, and manages various properties; and provides professional property services, as well as engages in the food and distribution business. The Bidvest Group Limited was founded in 1988 and is headquartered in Johannesburg, South Africa.

Full BDVSY Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this BDVSY vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BDVSY vs SCHDBDVSY vs JEPIBDVSY vs OBDVSY vs KOBDVSY vs MAINBDVSY vs JNJBDVSY vs MRKBDVSY vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.